Gilead Sciences has signed an agreement to acquire Repare Therapeutics’ polymerase theta (Polθ) ATPase inhibitor, RP-3467.

Chicago Catholics attending Christmas mass at Holy Name Cathedral downtown said they are filled with pride seeing Pope Leo ...

Negativity bias also affects our investment decisions. If we hear news about a company that is equally divided between both good and bad, for example, we're likely to be more pessimistic than ...

Already a familiar face on ESPN’s Monday Night Football and co-host of the hit podcast New Heights, Kelce is adding a spicy ...

Two of our top-performing holdings were SanDisk and Western Digital in the Information Technology sector. Read more here.

Berkshire Hathaway's portfolio is heavily weighted toward cash, Treasuries, and non-tech operating businesses. Read why BRK.B ...